Overview

  • Product nameTreponema pallidum p17 protein

Description

  • NatureRecombinant
  • SourceE. coli
  • Amino Acid Sequence
    • Additional sequence informationThe protein contains the Tr.pallidum p17 immunodominant regions.

Specifications

Our Abpromise guarantee covers the use of ab43053 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Biological activityImmunoreactive with sera of Tr.pallidum - infected individuals.
  • Applications

    ELISA

    Western blot

  • Purity> 90 % by SDS-PAGE.
    Inclusion bodies.
  • FormLiquid
  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

    Preservative: None
    Constituents: 8M Urea, 10mM Tris HCl, 1mM EDTA, 1mM DTT, pH 8

General info

  • RelevanceSyphilis is a chronic, complex sexually transmitted disease of humans caused by the spirochetal bacterium Treponema pallidum. Primary syphilis is characterized by the prevalence of IgG to protein p41 with the total antibody level being low, while early latent syphilis is characterized mainly by prevalence of IgG to protein p17 in the presence of high titers of antibodies.
  • Cellular localizationCell Membrane

References for Treponema pallidum p17 protein (ab43053)

ab43053 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab43053.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"